In the past 25 years – an era that has seen the development of disease-modifying treatments for MS – prognosis has substantially changed and there has been profound reduction of two time frames after the diagnosis of clinically isolated syndromes (CIS): the time to diagnosis of MS (by 68%) and the time to treatment initiation (by 84%), specialists have reported.